CAS: 1844849-10-0
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | PF 06821497 REF: 3D-UYC84910CAS: 1844849-10-0 | Min. 95% | To inquire | Wed 15 Jan 25 |
 | PF-06821497 REF: TM-T12430CAS: 1844849-10-0 | 97.88% | 94.00 €~918.00 € | Wed 19 Mar 25 |
PF 06821497
CAS:1844849-10-0
PF 06821497 is a potential drug for the treatment of Creutzfeldt-Jakob disease (CJD). It is …
Formula:
C22H24Cl2N2O5
Purity:
Min. 95%
Molecular weight:
467.3 g/mol
Ref: 3D-UYC84910
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Wednesday 15 Jan 2025
PF-06821497
CAS:1844849-10-0
PF-06821497 is a selective inhibitor of EZH2 with significant tumor growth inhibition.Cost-effective and quality-assured.
Formula:
C22H24Cl2N2O5
Purity:
97.88%
Color and Shape:
Solid
Molecular weight:
467.34
Ref: TM-T12430
| 1mg | 94.00 € | ||
| 5mg | 223.00 € | ||
| 10mg | 346.00 € | ||
| 25mg | 523.00 € | ||
| 50mg | 732.00 € | ||
| 100mg | 918.00 € | ||
| 1mL*10mM (DMSO) | 207.00 € |
Estimated delivery in United States, on Wednesday 19 Mar 2025
